Scrip dividend share allotment
Summary by AI BETAClose X
NewRiver REIT plc announced the allotment of 2,916,262 ordinary shares of 1p each, expected to be admitted to trading on 7 August 2026. These shares are being issued to shareholders who elected to participate in the Scrip Dividend Scheme for the final dividend covering the six months ended 31 March 2026. The newly issued shares will rank equally with existing ordinary shares.
NewRiver REIT PLC
03 August 2026
3 August 2026
NewRiver REIT plc
("NewRiver" or the "Company")
Scrip dividend share allotment
Application has been made to the London Stock Exchange Plc for a total of 2,916,262 Ordinary Shares of 1p each ('Shares') to be admitted to trading.
Admission of the Shares is expected on 7 August 2026.
The Shares are being issued in respect of elections to participate in the Scrip Dividend Scheme in respect of the final dividend for the six months ended 31 March 2026.
The Shares will rank pari passu with the existing Ordinary Shares.
Ends
For further information
|
NewRiver REIT plc |
|
|
+44 (0)20 3328 5800 |
|
Jenny Warburton Company Secretary |
|
|
|
|
|
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago RIT Capital Partners
- 1 hour ago Legal & General Group
- 1 hour ago BioPharma Credit
- 2 hours ago BioPharma Credit
- 2 hours ago Great Portland Estates